跳至主要内容
临床试验/ACTRN12616000323426
ACTRN12616000323426已完成未知

Home assessment visits prior to discharge from hospital on rates of falls and re-admission to hospital for patients after hip fracture: A randomised controlled trial

Professor Nicholas Taylor0 个研究点目标入组 74 人开始时间: 2016年3月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • People will be invited to participate provided they meet the following inclusion criteria:-
  • a) Admitted as an inpatient to an Eastern Health hospital
  • b) Adults greater than or equal to 50 years of age because from 50 years of age risk of falling and incidence rates of hip fracture rise dramatically
  • c) Primary diagnosis of hip fracture as determined by the International Classification of Diseases, 10th edition codes S72.00 - S72.11
  • d) Living in a private residence in the community prior to the hip fracture
  • e) Not demonstrating risk factors at admission that would suggest a length of stay greater than 28 days (eg. Particularly complex social situation or extensive co-morbidities)

排除标准

  • Participants will be excluded if they are:
  • a) Admitted from a residential care facility because this population would not be expected to receive a home assessment visit
  • b) Patients who fracture their hip during an inpatient admission because this would not be a primary diagnosis
  • c) Assessed as having impaired cognition and do not have a carer or responsible person who can give informed consent
  • d) Planned to be discharged to a residential aged care facility because a home visit would not normally be considered as a component of the discharge plan for these patients
  • e) Living in a location more than 1 hour by car from the hospital because it would not be practical to complete a home assessment visit due to distance

研究者

发起方
Professor Nicholas Taylor

相似试验

Home assessment visits prior to discharge from... | 临床试验